养老院临终镇静用药的回顾性多中心队列研究
该研究回顾德国4家养老院2015年1月至2017年12月死亡的512例住民病历,评估临终最后一周镇静药使用。110/512(21%)至少使用一次镇静药,46/512(9%)使用持续效应镇静药,仅11/512(2%)剂量达至少中度镇静;最常见指征为激越与焦虑,33%无记录指征。
要点
- 临终最后一周21%住民使用镇静药,9%为持续效应镇静药。
- 最常用为口服劳拉西泮,仅2%剂量达至少中度镇静。
- 使用与年龄(OR=0.94)及机构(P<.001)相关,机构间差异明显。
核心结论
- 养老院临终镇静使用率低于国际数据,且机构间差异较大,需探索支持措施以统一最佳实践。
研究设计与样本
- 回顾性多中心队列研究,使用4家德国养老院病历,纳入2015年1月至2017年12月死亡且病历可及的住民n=512。
主要发现
- 110/512(21%)住民临终最后一周至少使用一次镇静药,46/512(9%)使用持续效应镇静药。
- 口服劳拉西泮最常用,11/512(2%)住民剂量达至少中度镇静。
- 最常见指征为激越58/110(53%)与焦虑35/110(32%),36/110(33%)无记录指征。
- 住民参与镇静决策的记录仅3/110(3%)。
- 多因素logistic回归显示镇静药使用与年龄(OR=0.94,P<.001)及机构(P<.001)显著相关。
关键数值与推荐
- 镇静药分析范围为依据指南推荐用于姑息镇静的药物:苯二氮䓬类、左美丙嗪、氟哌啶醇(≥5 mg/d)及丙泊酚。
- 持续效应镇静药定义及至少中度镇静剂量由姑息治疗临床医生与药师基于文献共识确定。
临床怎么用
- 养老院临终镇静应记录指征并让住民参与决策,同时关注机构间实践差异。
局限性
- 仅为4家德国养老院的回顾性病历研究,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: There is scarce information about sedation in nursing homes at the end of life. We aimed to assess (1) the use of sedatives generally and "sedatives with continuous effect," based on objective operational criteria, within the last week of life in nursing homes and (2) factors associated with this treatment. DESIGN: Retrospective cohort study, using the nursing homes' medical records. SETTING AND PARTICIPANTS: Residents who died in 4 German nursing homes from January 2015 to December 2017 and whose medical records were available (n = 512). METHODS: Sedatives analyzed were those recommended by guidelines for "palliative sedation": benzodiazepines, levomepromazine, haloperidol (≥5 mg/d), and propofol. The definition of "sedatives with continuous effect" and doses judged as at least moderately sedating were consented by palliative care clinicians and pharmacists, based on the literature. Descriptive statistics and multivariate logistic regression analysis were performed (R version 3.6.1). RESULTS: Overall, 110/512 (21%) deceased residents received a sedative at least once during the last week of life, 46/512 (9%) "sedatives with continuous effect." Oral lorazepam was used most frequently. Eleven of 512 (2%) residents received doses judged as at least moderately sedating. The term sedation was not used. Most frequent indications were agitation (58/110; 53%) and anxiety (35/110; 32%); no indication was noted for 36/110 (33%) residents. The resident's involvement in the decision for sedatives was documented in 3/110 (3%). Multivariate logistic regression analysis showed significant associations between use of sedatives and age (OR = 0.94, P < .001) as well as institution (P < .001). CONCLUSIONS AND IMPLICATIONS: Our data indicate a lower prevalence of sedation compared to international data and considerable differences regarding prevalence between institutions. These differences, potential setting-specific challenges, and need for support measures for consistent best practice of sedation in nursing homes should be further explored.
引用
- Schildmann E, Meesters S, Grüne B, et al. Sedatives and Sedation at the End of Life in Nursing Homes: A Retrospective Multicenter Cohort Study. J Am Med Dir Assoc. 2020. PMID: 33041234. doi:10.1016/j.jamda.2020.08.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。